Alglucosidase alfa

Therapeutic indications

Alglucosidase alfa is indicated for:

Pompe disease

Population group: both men and women, only infants (40 days - 1 year old) , children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)

Alglucosidase alfa is indicated for long-term enzyme replacement therapy (ERT) in patients with a confirmed diagnosis of Pompe disease (acid α-glucosidase deficiency). It is indicated in adults and paediatric patients of all ages.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1: Intravenous - 20 mg/kg once every 2 weeks


Alglucosidase alfa is contraindicated in the following cases:





Medication Recommendation

Receive personalized medication regimen for every patient case

Ask the Reasoner

Related medicines